17. Biomarkers
Breast Cancer 2026 presents the growing significance of biomarkers as measurable biological indicators used for diagnosis, prognosis, and therapeutic monitoring. They provide critical information for precision oncology.
Supports individualized patient management through accurate and evidence-based decision-making.
Key Highlights:
17.1 Diagnostic Biomarkers
17.2 Prognostic Indicators
17.3 Predictive Markers
17.4 Therapeutic Monitoring
17.5 Biomarker Validation